247 related articles for article (PubMed ID: 27667550)
1. Anti-tubercular activities of 5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4-amine analogues endowed with high activity toward non-replicative Mycobacterium tuberculosis.
Samala G; Brindha Devi P; Saxena S; Gunda S; Yogeeswari P; Sriram D
Bioorg Med Chem; 2016 Nov; 24(21):5556-5564. PubMed ID: 27667550
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of 4',5'-dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran] analogues against both active and dormant Mycobacterium tuberculosis.
Alluri KK; Reshma RS; Suraparaju R; Gottapu S; Sriram D
Bioorg Med Chem; 2018 May; 26(8):1462-1469. PubMed ID: 29501415
[TBL] [Abstract][Full Text] [Related]
3. Development of novel tetrahydrothieno[2,3-c]pyridine-3-carboxamide based Mycobacterium tuberculosis pantothenate synthetase inhibitors: molecular hybridization from known antimycobacterial leads.
Samala G; Devi PB; Nallangi R; Sridevi JP; Saxena S; Yogeeswari P; Sriram D
Bioorg Med Chem; 2014 Mar; 22(6):1938-47. PubMed ID: 24565972
[TBL] [Abstract][Full Text] [Related]
4. Design and development of novel Mycobacterium tuberculosis L-alanine dehydrogenase inhibitors.
Saxena S; Samala G; Sridevi JP; Devi PB; Yogeeswari P; Sriram D
Eur J Med Chem; 2015 Mar; 92():401-14. PubMed ID: 25585006
[TBL] [Abstract][Full Text] [Related]
5. Design and development of new class of Mycobacterium tuberculosisl-alanine dehydrogenase inhibitors.
Reshma RS; Saxena S; Bobesh KA; Jeankumar VU; Gunda S; Yogeeswari P; Sriram D
Bioorg Med Chem; 2016 Sep; 24(18):4499-4508. PubMed ID: 27477207
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of imidazo[2,1-b]thiazole and benzo[d]imidazo[2,1-b]thiazole derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
Samala G; Devi PB; Saxena S; Meda N; Yogeeswari P; Sriram D
Bioorg Med Chem; 2016 Mar; 24(6):1298-307. PubMed ID: 26867485
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of substituted 4,6-diarylpyrimidines and 3,5-diphenyl-4,5-dihydro-1H-pyrazoles as anti-tubercular agents.
Pathak V; Maurya HK; Sharma S; Srivastava KK; Gupta A
Bioorg Med Chem Lett; 2014 Jul; 24(13):2892-6. PubMed ID: 24835631
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, in vitro antimycobacterial evaluation and docking studies of some new 5,6,7,8-tetrahydropyrido[4',3':4,5]thieno[2,3-d]pyrimidin-4(3H)-one schiff bases.
Narender M; Jaswanth S B; Umasankar K; Malathi J; Raghuram Reddy A; Umadevi KR; Dusthackeer AVN; Venkat Rao K; Raghuram R A
Bioorg Med Chem Lett; 2016 Feb; 26(3):836-840. PubMed ID: 26755393
[TBL] [Abstract][Full Text] [Related]
9. Novel amide and sulphonamide derivatives of 6-(piperazin-1-yl)phenanthridine as potent Mycobacterium tuberculosis H37Rv inhibitors.
Naidu KM; Nagesh HN; Singh M; Sriram D; Yogeeswari P; Gowri Chandra Sekhar KV
Eur J Med Chem; 2015 Mar; 92():415-26. PubMed ID: 25590862
[TBL] [Abstract][Full Text] [Related]
10. Thienopyrimidines as novel inhibitors of Mycobacterium tuberculosis: synthesis and in-vitro studies.
Rashmi P; Nargund LV; Hazra K; Chandra JN
Arch Pharm (Weinheim); 2011 Jul; 344(7):459-65. PubMed ID: 21598298
[TBL] [Abstract][Full Text] [Related]
11. Discovery of novel lysine ɛ-aminotransferase inhibitors: An intriguing potential target for latent tuberculosis.
Devi PB; Sridevi JP; Kakan SS; Saxena S; Jeankumar VU; Soni V; Anantaraju HS; Yogeeswari P; Sriram D
Tuberculosis (Edinb); 2015 Dec; 95(6):786-794. PubMed ID: 26299907
[TBL] [Abstract][Full Text] [Related]
12. Development of antimycobacterial tetrahydrothieno[2,3-c]pyridine-3-carboxamides and hexahydrocycloocta[b]thiophene-3-carboxamides: Molecular modification from known antimycobacterial lead.
Nallangi R; Samala G; Sridevi JP; Yogeeswari P; Sriram D
Eur J Med Chem; 2014 Apr; 76():110-7. PubMed ID: 24583350
[TBL] [Abstract][Full Text] [Related]
13. Simple approach to thieno[3,2-d]pyrimidines as new scaffolds of antimicrobial activities.
Hafez HN; El-Gazzar AR; Zaki ME
Acta Pharm; 2016 Sep; 66(3):331-51. PubMed ID: 27383884
[TBL] [Abstract][Full Text] [Related]
14. Identification and development of 2-methylimidazo[1,2-a]pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
Samala G; Nallangi R; Devi PB; Saxena S; Yadav R; Sridevi JP; Yogeeswari P; Sriram D
Bioorg Med Chem; 2014 Aug; 22(15):4223-32. PubMed ID: 24953948
[TBL] [Abstract][Full Text] [Related]
15. Lead identification and optimization of bacterial glutamate racemase inhibitors.
Malapati P; Siva Krishna V; Nallangi R; Meda N; Reshma Srilakshmi R; Sriram D
Bioorg Med Chem; 2018 Jan; 26(1):177-190. PubMed ID: 29239770
[TBL] [Abstract][Full Text] [Related]
16. Hit discovery of Mycobacterium tuberculosis inosine 5'-monophosphate dehydrogenase, GuaB2, inhibitors.
Sahu NU; Singh V; Ferraris DM; Rizzi M; Kharkar PS
Bioorg Med Chem Lett; 2018 Jun; 28(10):1714-1718. PubMed ID: 29699922
[TBL] [Abstract][Full Text] [Related]
17. 5-Nitro-2,6-dioxohexahydro-4-pyrimidinecarboxamides: synthesis, in vitro antimycobacterial activity, cytotoxicity, and isocitrate lyase inhibition studies.
Sriram D; Yogeeswari P; Senthilkumar P; Naidu G; Bhat P
J Enzyme Inhib Med Chem; 2010 Dec; 25(6):765-72. PubMed ID: 20569083
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, Antimycobacterial Evaluation and Docking Studies of Some 7-Methyl-5,6,7,8-tetrahydropyrido[4',3':4,5]thieno[2,3-d]pyrimidin-4(3H)-ones.
Malothu N; Kulandaivelu U; Jojula M; Gunda SK; Akkinepally RR
Chem Pharm Bull (Tokyo); 2018; 66(10):923-931. PubMed ID: 30270239
[TBL] [Abstract][Full Text] [Related]
19. Facile transformation of Biginelli pyrimidin-2(1H)-ones to pyrimidines. In vitro evaluation as inhibitors of Mycobacterium tuberculosis and modulators of cytostatic activity.
Singh K; Singh K; Wan B; Franzblau S; Chibale K; Balzarini J
Eur J Med Chem; 2011 Jun; 46(6):2290-4. PubMed ID: 21450375
[TBL] [Abstract][Full Text] [Related]
20. Design and development of ((4-methoxyphenyl)carbamoyl) (5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazol-2-yl)amide analogues as Mycobacterium tuberculosis ketol-acid reductoisomerase inhibitors.
Krishna VS; Zheng S; Rekha EM; Nallangi R; Sai Prasad DV; George SE; Guddat LW; Sriram D
Eur J Med Chem; 2020 May; 193():112178. PubMed ID: 32171154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
